Last updated 18 days ago

A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

270 patients around the world
Available in United States, Argentina
Insmed Incorporated
270Patients around the world
This study is for people with
Rhinosinusitis
Chronic Rhinosinusitis
Requirements for the patient
To 75 Years
All Gender
Medical requirements
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy